5-ヒドロキシトリプタミン1aレセプター活性増強化合物を用いる運動症状の変動の治療
- 专利权人:
- モタック・ニューロサイエンス・リミテッド
- 发明人:
- ジョナサン・ブロチー,マイケル・ヒル
- 申请号:
- JP2002538919
- 公开号:
- JP5189240B2
- 申请日:
- 2001.10.29
- 申请国别(地区):
- JP
- 年份:
- 2013
- 代理人:
- 摘要:
- The invention relates to the use of compounds that enhance 5-hydroxytryptamine 1a receptor activity, or activation (e.g. a selective 5-hydroxytryptamine 1a receptor agonists) for preventing or reducing motor fluctuations associated with dopamine replacement therapy.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Treatment of motor fluctuations
- simple variable domain, multispecific ligand, tnfr1, and tnf-alpha receptor antagonists, use of tnfr agonist, anti-tnfr1 antagonist, polypeptide or multispecific ligand, method for treating and / or preventing a condition or disease, nucleic acid, vector and host
- NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR RYR2 AND USES THEREOF
- APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS
- TUMOUR NECROSIS FACTOR RECEPTOR 1 ANTAGONISTS